270 related articles for article (PubMed ID: 26267749)
1. Coronary spasm revascularized with a bioresorbable vascular scaffold.
Bil J; Pawlowski T; Gil RJ
Coron Artery Dis; 2015 Nov; 26(7):634-6. PubMed ID: 26267749
[No Abstract] [Full Text] [Related]
2. Complex coronary artery bifurcation treatment utilizing everolimus-eluting bioresorbable vascular scaffolds and optical coherence tomography.
Chan W; Shah A; Džavík V; Overgaard CB
Coron Artery Dis; 2014 Nov; 25(7):629-31. PubMed ID: 25248139
[No Abstract] [Full Text] [Related]
3. Follow-up evaluation of unapposed bioresorbable vascular scaffold at a coronary bifurcation using optical coherence tomography.
Danson E; Bhindi R; Hansen P
Int J Cardiol; 2014 Dec; 177(2):e84-6. PubMed ID: 25456696
[No Abstract] [Full Text] [Related]
4. Initial experience of percutaneous coronary intervention in bifurcations with bioresorbable vascular scaffolds using different techniques--insights from optical coherence tomography.
Attizzani GF; Ohno Y; Capranzano P; La Manna A; Francaviglia B; Grasso C; Sgroi C; Tamburino C; Longo G; Fujino Y; Capodanno D; Tamburino C
Int J Cardiol; 2013 Dec; 170(2):e33-5. PubMed ID: 24210418
[No Abstract] [Full Text] [Related]
5. Incidence and imaging outcomes of acute scaffold disruption and late structural discontinuity after implantation of the absorb Everolimus-Eluting fully bioresorbable vascular scaffold: optical coherence tomography assessment in the ABSORB cohort B Trial (A Clinical Evaluation of the Bioabsorbable Everolimus Eluting Coronary Stent System in the Treatment of Patients With De Novo Native Coronary Artery Lesions).
Onuma Y; Serruys PW; Muramatsu T; Nakatani S; van Geuns RJ; de Bruyne B; Dudek D; Christiansen E; Smits PC; Chevalier B; McClean D; Koolen J; Windecker S; Whitbourn R; Meredith I; Garcia-Garcia HM; Veldhof S; Rapoza R; Ormiston JA
JACC Cardiovasc Interv; 2014 Dec; 7(12):1400-11. PubMed ID: 25523532
[TBL] [Abstract][Full Text] [Related]
6. Percutaneous coronary intervention with everolimus-eluting bioresorbable vascular scaffolds in routine clinical practice: early and midterm outcomes from the European multicentre GHOST-EU registry.
Capodanno D; Gori T; Nef H; Latib A; Mehilli J; Lesiak M; Caramanno G; Naber C; Di Mario C; Colombo A; Capranzano P; Wiebe J; Araszkiewicz A; Geraci S; Pyxaras S; Mattesini A; Naganuma T; Münzel T; Tamburino C
EuroIntervention; 2015 Feb; 10(10):1144-53. PubMed ID: 25042421
[TBL] [Abstract][Full Text] [Related]
7. Feasibility and efficacy of bioresorbable vascular scaffolds use for the treatment of in-stent restenosis and a bifurcation lesion in a heavily calcified diffusely diseased vessel.
Naganuma T; Costopoulos C; Latib A; Sato K; Miyazaki T; Colombo A
JACC Cardiovasc Interv; 2014 May; 7(5):e45-6. PubMed ID: 24746654
[No Abstract] [Full Text] [Related]
8. Coronary erosion following ST-elevated vasospastic coronary obstruction observed by coronary angioscopy.
Kitano D; Yoda S; Fukamachi D; Okumura Y
Int J Cardiovasc Imaging; 2020 Jul; 36(7):1191-1192. PubMed ID: 32189160
[No Abstract] [Full Text] [Related]
9. Clinical utility of optical coherence tomography (OCT) in the optimisation of Absorb bioresorbable vascular scaffold deployment during percutaneous coronary intervention.
Allahwala UK; Cockburn JA; Shaw E; Figtree GA; Hansen PS; Bhindi R
EuroIntervention; 2015 Feb; 10(10):1154-9. PubMed ID: 24647105
[TBL] [Abstract][Full Text] [Related]
10. Five-year follow-up of the ABSORB bioresorbable everolimus-eluting vascular scaffold system: multimodality imaging assessment.
García-García HM; Schultz C; Duckers E; Regar E; Ligthart J; Serruys PW; van Geuns RJ
EuroIntervention; 2013 Feb; 8(10):1126-7. PubMed ID: 23014900
[No Abstract] [Full Text] [Related]
11. Bioresorbable scaffold T-stenting evaluated with optical coherence tomography.
Ortiz C; Gutiérrez H; San Román JA
Rev Esp Cardiol (Engl Ed); 2014 Nov; 67(11):949. PubMed ID: 25443817
[No Abstract] [Full Text] [Related]
12. A case of true left main bifurcation treated with bioresorbable everolimus-eluting stent v-stenting.
Sato K; Latib A; Panoulas VF; Naganuma T; Miyazaki T; Colombo A
JACC Cardiovasc Interv; 2014 Aug; 7(8):e103-4. PubMed ID: 25086841
[No Abstract] [Full Text] [Related]
13. No more metallic cages: an attractive hybrid strategy with bioresorbable vascular scaffold and drug-eluting balloon for diffuse or tandem lesions in the same vessel.
Naganuma T; Latib A; Ielasi A; Panoulas VF; Sato K; Miyazaki T; Colombo A
Int J Cardiol; 2014 Apr; 172(3):618-9. PubMed ID: 24495653
[No Abstract] [Full Text] [Related]
14. Coronary artery aneurysms formation within Everolimus-eluting stents and bioresorbable vascular scaffolds.
Lee WC; Chung WJ; Fang HY; Wu CJ
Int J Cardiol; 2016 Mar; 206():58-60. PubMed ID: 26774833
[No Abstract] [Full Text] [Related]
15. Coregistered intravascular ultrasound and optical coherence tomography imaging during implantation of a bioresorbable vascular scaffold.
Brown AJ; McCormick LM; Hoole SP; West NE
JACC Cardiovasc Interv; 2013 Jul; 6(7):e41-2. PubMed ID: 23866193
[No Abstract] [Full Text] [Related]
16. Definite and probable bioresorbable scaffold thrombosis in stable and ACS patients.
Ishibashi Y; Nakatani S; Onuma Y
EuroIntervention; 2015 Jul; 11(3):e1-2. PubMed ID: 25243382
[No Abstract] [Full Text] [Related]
17. Head-to-head comparison of the neointimal response between metallic and bioresorbable everolimus-eluting scaffolds using optical coherence tomography.
Gomez-Lara J; Brugaletta S; Farooq V; Onuma Y; Diletti R; Windecker S; Thuesen L; McClean D; Koolen J; Whitbourn R; Dudek D; Smits PC; Chevalier B; Regar E; Veldhof S; Rapoza R; Ormiston JA; Garcia-Garcia HM; Serruys PW
JACC Cardiovasc Interv; 2011 Dec; 4(12):1271-80. PubMed ID: 22192368
[TBL] [Abstract][Full Text] [Related]
18. Optical coherence tomography evaluation of overlapping everolimus-eluting bioresorbable vascular scaffold implantation guided by enhanced stent visualization system.
Biscaglia S; Secco GG; Tumscitz C; Di Mario C; Campo G
Int J Cardiol; 2015 Mar; 182():1-3. PubMed ID: 25590956
[No Abstract] [Full Text] [Related]
19. Current status of bioresorbable scaffolds in the treatment of coronary artery disease.
Wiebe J; Nef HM; Hamm CW
J Am Coll Cardiol; 2014 Dec; 64(23):2541-51. PubMed ID: 25500240
[TBL] [Abstract][Full Text] [Related]
20. Bioresorbable Vascular Scaffold for the Treatment of Coronary Bifurcation Lesions: Immediate Results and 1-year Follow-up.
Suárez de Lezo J; Martín P; Pan M; Ojeda S; Nóvoa J; Segura J; Mazuelos F; Romero M; Medina A; Suárez de Lezo J
Rev Esp Cardiol (Engl Ed); 2016 Jun; 69(6):554-62. PubMed ID: 26949014
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
